EIF2B2 Antibody
- 
								中文名稱:EIF2B2兔多克隆抗體
- 
								貨號(hào):CSB-PA007515GA01HU
- 
								規(guī)格:¥3,900
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:EIF2B2
- 
											別名:EI2BB_HUMAN antibody; EIF 2Bbeta antibody; EIF-2Bbeta antibody; EIF2B antibody; EIF2B GDP GTP exchange factor subunit beta antibody; EIF2B2 antibody; EIF2B2 antibody antibody; EIF2BB antibody; Eukaryotic translation initiation factor 2B antibody; Eukaryotic translation initiation factor 2B beta antibody; Eukaryotic translation initiation factor 2B; subunit 2 antibody; Eukaryotic translation initiation factor 2B; subunit 2 beta antibody; Eukaryotic translation initiation factor 2B; subunit 2 beta; 39kDa antibody; S20I15 antibody; S20III15 antibody; Translation initiation factor eIF-2B subunit beta antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human,Mouse,Rat
- 
											免疫原:Human EIF2B2
- 
											免疫原種屬:Homo sapiens (Human)
- 
											抗體亞型:IgG
- 
											純化方式:Antigen Affinity Purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:ELISA,WB,IHC
- 
											Protocols:
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
- 
											功能:Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.
- 
											基因功能參考文獻(xiàn):- Data show that eIF2Balpha and eIF2Bbeta bind to adjacent surfaces on eIF2alpha-N-terminal domains (NTDs). PMID: 29036434
- It would be better to consider Vanishing White Matter Disease as an eIF2B-related multisystem disorder, not just as a neurological disorder. PMID: 28041799
- An Italian patient is described with a c.638A>G mutation in exon 5 of EIF2B2 gene with very slow progressive vanishing white matter disease. PMID: 22729508
- analysis of vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype [case report] PMID: 22285377
- Mutation in EIF2B2 causes childhood ataxia with central nervous system hypomyelination/ vanishing white matter leukodystrophy. PMID: 12707859
- Biochemical analyses indicate that mutations analyzed in eIF2Balpha and -epsilon reduce the steady-state level of the affected subunit, while the most severe mutant tested, eIF2Bbeta(V341D), forms complexes with reduced stability and lower eIF2B activity. PMID: 14993275
- The role of the residues Ser2 and Ser67 contribute to the important role of the N-terminal region of eIF2beta for its function in mammals. PMID: 16225457
- CACH syndrome is linked to mutations in the five EIF2B--REVIEW PMID: 17878805
- Study reports 9 novel mutations in EIF2B genes in 8 patients, increasing number of known mutations to >120. Using homology modeling, analyzed the impact of novel mutations on the 5 subunits of eIF2B protein (alpha, beta, gamma, delta, epsilon). PMID: 18263758
 顯示更多 收起更多 
- 
											相關(guān)疾病:Leukodystrophy with vanishing white matter (VWM)
- 
											蛋白家族:EIF-2B alpha/beta/delta subunits family
- 
											數(shù)據(jù)庫鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          